Diluted Bothrops Atrox Time (Dbat). A New Assay to Detect Lupus Anticoagulant

Descripción del Articulo

OBJECTIVE: To validate a new assay for lupus anticoagulant (LA) that employs crude diluted venom of Bothrops atrox (dBat) comparing it with four phospholipid - dependent assays. MATERIAL AND METHODS: Citrated serum samples from 70 inpatients clinically diagnosed as having SLE, primary antiphospholip...

Descripción completa

Detalles Bibliográficos
Autor: Oviedo Donayre, Pilar
Formato: artículo
Fecha de Publicación:2000
Institución:Universidad Nacional Mayor de San Marcos
Repositorio:Revistas - Universidad Nacional Mayor de San Marcos
Lenguaje:español
OAI Identifier:oai:ojs.csi.unmsm:article/4244
Enlace del recurso:https://revistasinvestigacion.unmsm.edu.pe/index.php/anales/article/view/4244
Nivel de acceso:acceso abierto
Materia:Thrombosis
Crotalid Venoms
Anticoagulants
Lupus Erythematosus
Systemic
Blood Coagulation Factors
Trombosis
Venenos de Crotálidos
Anticoagulantes
Lupus Eritematoso Sistémico
Factores de Coagulación Sanguínea
Descripción
Sumario:OBJECTIVE: To validate a new assay for lupus anticoagulant (LA) that employs crude diluted venom of Bothrops atrox (dBat) comparing it with four phospholipid - dependent assays. MATERIAL AND METHODS: Citrated serum samples from 70 inpatients clinically diagnosed as having SLE, primary antiphospholipid syndrome (PAPS), thrombosis/embolism or suspected thrombosis from the Hospital Guillermo Almenara Irigoyen over 12 months, were assayed. dRVVT was used as comparative test for reference values. RESULTS: 30 samples were positive to dBat and dRVVT tests plus at least another one of the remain assays; 27 samples had negative results in all assays and there were 13 in which dBat results had not concordance with dRVVT results (p>0,05). 47,8% of SLE, 71,4% of PAPS, 75% of thrombosis and 47,8% of suspected thrombosis cases were LA (+). CONCLUSIONS: The high concordance between dBat and dRVVT results, higher that those found with another tests, as well as their close relationship with clinical features, permit us to conclude that dBat assay can be used to detect LA.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).